Biography
Interests
Abd Al-Aziz Aboamo, K.1*, Mahmoud Eldestawy, T.2 & Usama Madany, M.3
1Faculty of Oral and Dental Medicine, Dental Medicine, Periodontology, Oral Radiology and Diagnosis, Master's
Degree in Dentistry (2017), Lecturer Assistant at Al-Azhar University, Boys, Cairo, Egypt
2Faculty of Oral and Dental Medicine, Dental Medicine, Periodontology, Oral Radiology and Diagnosis, Assistant
Professor at Al-Azhar University, Boys, Cairo, Egypt
3Faculty of Oral and Dental Medicine, Dental Medicine, Periodontology, Oral Radiology and Diagnosis, Professor
at Al-Azhar University, Boys, Cairo, Egypt
*Correspondence to: Dr. Abd Al-Aziz Aboamo, K., Faculty of Oral and Dental Medicine, Dental Medicine, Periodontology, Oral Radiology and Diagnosis, Master's Degree in Dentistry (2017), Lecturer Assistant at Al-Azhar University, Boys, Cairo, Egypt.
Copyright © 2021 Dr. Abd Al-Aziz Aboamo, K., et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
This study aimed to evaluate the efficacy of PRF either alone, or mixed with 1% metformin gel, in horizontal ridge augmentation with split-crest technique, for implant placement.
24 implants were inserted in narrow ridges of twelve patients who were randomly assigned into one
of two groups. In group 1, patients were treated by split crest technique with implant placement and PRF only. In group 2, patients received SCT with implant placement and 1% metformin gel mixed
with PRF. Implant stability was recorded for every single implant immediately after insertion
during surgery, and at 6 months. Modified Gingival Index, modified Plaque Index, and probing
depth were recorded and repeated at one, 3, and 6 months. Immediately after surgery, at the time
of loading, and 6 months after loading ridge width, crestal bone loss as well as bone density were
evaluated.
The mean alveolar crest width, bone density and implant stability measurements were significantly
higher in metformin mixed with PRF group than PRF alone. Crestal bone loss (CBL) measurements
were lower in metformin mixed with PRF group than PRF alone.
The results of the present study may provide a clinical evidence for the possible osteogenic potential
of MF, indicated that, adding it to PRF which is known with short time stability may increase its
therapeutic performance.
Abbreviations
SCT: split crest technique
MF: metformin
PRF: Platelet rich fibrine
MGI: Modified gingival index
MPI: Modified plaque index
PD: Probing depth
RBD: Relative bone density
CBL: Crestal bone loss
ACW: Alveolar crest width
Introduction
Insufficient alveolar ridge is common for edentulous patients, especially when alveolar fracturing occurs during
dental extraction. When the bone loss results from a maxillofacial trauma, or from extensive periodontal/
endodontic diseases, the effects are even more severe. These factors might result in insufficient vertical and
horizontal support for installing dental implants and may impair, or even limit, the options for prosthetic
rehabilitation. In such cases, bone volume improving techniques may be considered as effective alternative
treatment [1]. split Crest technique (SCT) [2] is a surgical procedure that divides the cortical bone crests,
moving them to create an opening in the center, which is then mainly occupied by simultaneously inserted
implants. The main benefit of the SCT is the simple, quick, and predictable way in which the alveolar
atrophic crest can be expanded [3].
The areas around implants (peri-implant gabs) can be filled with bone grafts or substitutes [4], as well as autologous biological therapies such as PRF [5]. This permits the use of bone grafts without the need for a second surgical site, thereby minimizing the risk of oedema, nerve injury, and pain [3].
In clinical practice, PRF has already been largely applied as an inexpensive carrier and way to obtain many growth factors in physiological proportions. This natural material seems to accelerate the physiological wound healing with or without bone grafts to accelerate new bone formation and hence, enhancing bone regeneration [6]. PRF has been successfully used as a sole filling material during a simultaneous SCT technique and implantation. It resulted in stabilizing high volumes of naturally regenerated bone in the spaces unoccupied by the implants [7-10].
Metformin (MF), an antidiabetic agent, that lately has been suggested to possesses osteogenic potential and induce the growth of osteoblast precursor cells. It has been successfully used as a local drug delivery agent in chronic periodontitis patients. Moreover, several human studies have reported the use of MF alone or combined with PRF in the treatment of bony defects [11-14].
Short time stability of PRF may not give it superiority over commonly used bone grafts in promoting bone formation [15]. Adding a medical formula with possible osteogenic potential such as MF to PRF may potentiate its therapeutic performance and may present a graft material, with an additional benefit of being cost-effective. Testing this hypothesis constituted the primary aim of work in the present study.
Subjects and Methods
In this study a total of 27 implants were inserted in 16 patients, 7 males, and 9 females, ranging in age from
23 to 45 years with the average of 38.7 years. The patients were divided into two groups and each group was
dedicated to PRF grafting (group 1), and MF mixed with PRF (group 2). Group 1 included 3 males and 5
females, 5 implants in the mandible, and 8 implants in the maxilla. Group 2 included 4 males and 4 females,
6 implants in the mandible, and 8 implants in the maxilla. All patients were recruited from the Outpatient
Clinic of the Department of Oral Medicine, Periodontology, Oral Diagnosis, and Oral Radiology, Faculty
of Dental Medicine, Boys, Cairo, Al-Azhar University. Clinical examination including taking medical and
dental histories, evaluation of general and oral health status, and assessment of future implant site was performed
for each patient. Radiographic evaluation was done using cone-beam computed tomography CBCT
using (Planmeca ProfaceTM 3 DX-ray unit) scan for assessment of bone height, width, mesiodistal space,
and inter-arch relationship (implant treatment plan). With Romix dental software (version 5.3.4.39 field of
view 8*10, voxel size 150 micron), it was possible to correctly assess the buccolingual width of each implant
site.
Before the surgery, each patient was given careful instructions on proper oral hygiene measures. Full mouth supra- and sub-gingival scaling and root planing procedures, if needed, were performed in quadrants under local anesthesia using a combination of hand Gracey curettes (Hu Friedy, Chicago, IL) and ultrasonic scaler with the P10 tip (Cavitron Corp., Long Island City, NY).
Patients were assigned into two groups (matched for age and gender) each group was dedicated after receiving an SCT by ultrasonic bone surgery with implant placement and use PRF only (Group 1), and metformin mixed with PRF (Group 2) as gap-filling materials.
A blood sample of 10 ccs was obtained from the patient for every single implant. The blood sample is then
put to a 10ml plain vacutainer without an anticoagulant and centrifuged at 3000 rpm for 10 min [16] using
Heraeus Megafuge 16R centrifuge. The result was platelet-poor plasma in the top of the tube, red corpuscles
in the bottom, and a fibrin clot (PRF) in-between. PRF clots were separated from the bottom layer and
placed in the PRF box until the time of use.
MF gel was prepared as described by Mohapatra et al. [17] Initially, dry gellan gum powder and distilled
water were mixed with a magnetic stirrer at 95°C for 20 min. Then the temperature was maintained at ≥80°C,
and mannitol was added. MF was incorporated in addition to the citric acid, sucralose, and preservatives
(propylparaben and methylparaben). The mixture was continuously stirred throughout the procedure. To
this mixture, the required amount of liquefied sodium citrate was incorporated. This blend produced a gel
at once, it was then cooled at around 20°C-25°C, and the concentration of the final MF gel was adjusted to
~1%.
The patients were initiated on a daily dose of antibiotic amoxicillin plus clavulanic acid twice daily about
20-25mg/kg/day (Augmentin 1g tab., MUP, Smithklin Ebeecham), one day before surgery as prophylactic.
One tablet from Ibuprofen 400mg (ibuprofen 400mg tab. SEDICO) and Paracetamol 500mg (Panadol
Alexandria, GLAXO Smithklin) were given to the patients an hour before surgery.
Surgical procedures were proceeded under local anesthesia using articaine hydrochloride 4% and epinephrine
(artinibsa, inbsa, Spain). After crestal incision, a full thickness mucoperiosteal flap to expose the donor area
was raised. A horizontal osteotomy terminated 2-3mm shorter in-depth than the full length of the planned
implant to ensure primary stability with a clearance of 1mm from the roots of adjacent teeth was performed
on the recipient alveolar using the CS1 and CS2 tips from the Crest-Splitting Kit of Peizotome Solo Led
(Satelec, Acteon, France).
After completion of osteotomy, the facial and lingual walls were separated apart by using the conical CS4, thereafter, CS5 and CS6 were then used gradually to increase the resulting osteotomy-gap.
Following sufficient lateralization of the buccal plate, the implant sites were prepared with progressive twist drills or threaded expanders up to the preimplant size. Then the implant (J dental care two-stage implant system) was placed submerged at least 1mm apical to the alveolar ridge crest. The gaps between or around dental implants were filled with Xenograft in group1, PRF in group 2and metformin mixed with PRF in group 3. The closure was tension-free performed with 3-0 black silk sutures by continuous interlocking and interrupted sutures.
The sutures were removed at 10 to 14 days, and the patients were maintained on the dose of antibiotics
(amoxicillin plus clavulanic acid twice daily, about 20-25mg/kg/day) for the next 5-7 days after surgery. The
analgesics were continued for the next 3-5 days. The Patients were placed on a systemically administered anti
edematous agent (Alphintern, Amoun pharmaceutical Co SAE) thrice daily half an hour before meals or
two hours after. The patients were instructed to use chlorhexidine mouthwash twice daily was up to 2 weeks.
At 6 months implant exposure was done under local anesthesia utilizing crestal incision followed by
unscrewing the covering screws and screwing the appropriate smart peg to each implant. Implant stability
was recorded (for the second time) for every single implant by placing the Osstell ISQ’s probe 2mm away
from the smart peg. Three measurements were recorded at different angles.
Healing abutments were then screwed to implants 10-14 days. Thereafter, the final restoration was fabricated and cemented to abutments with temporary cement. One month later (1M), the modified gingival index [18] (MGI), modified plaque index [18] (MPI), and probing depth (PD) were recorded and repeated at 3, and 6 months.
CBCT scans were taken (for the segment which includes the implant site to reduce the patient’s exposure
dose as possible.) immediately after surgery, at the time of loading, and 6 months after loading to evaluate
alveolar crest width (ACW), crestal bone loss (CBL) as well as relative bone density (RBD). The gray values
of the relative bone density around the implant were measured immediately after surgery, immediately after
implant insertion, at the time of loading, and 6 months after loading.
All data were expressed as mean ± SD of 6 patients. The statistical significance was evaluated by twoways
analysis of variance (ANOVA) using SPSS statistical software package version 21 and the post-hoc
individual comparisons were obtained by Duncan test. Differences were considered statistically significant
at p<0.05.
Results
p: p value for comparing between the studied groups
*: Statistically significant at p ≤ 0.05
p: p value for comparing between the studied groups
*: Statistically significant at p ≤ 0.05
Discussion
Many in vitro studies have pointed to bone anabolic effects of MF; increasing the bone-forming capacity
of osteoblasts and decreasing the recruitment and bone-resorbing activity of osteoclasts [19,20]. It can
protect osteoblasts against hypoxia-induced oxidative stress and alleviate hypoxia-enhanced apoptosis [21]. Moreover, upon local administration, osteoblasts can transport MF intracellularly, yet, decreasing drug
dosage, increasing drug concentration, and at the same time avoiding adverse systemic side effects [22]. In
the present study, narrow alveolar ridges were managed using crest split (Piezo-electric) and simultaneous
implant placement while, the resultant peri-implant gaps were filled with PRF (group1) alone or mixed with
1% MF (group2).
All implants were successfully placed, and the mean ISQs measurements were reasonable and almost close in both tested groups at the time of surgery. On the other hand, at loading, mean ISQs increased in group 2 (74.80) more than in group 1 (69.50). This might denote relatively better osseointegration process around and on the implant surfaces in group 2. The results of the present study agree with the results Gonzalez et. al. [1], Demetriades et al [23] and Jang et al. [6] , who measured implant stability in alveolar ridge expansion. Concerning the encountered results of MF, there is agreement between the current results and the results of Sharma et al. [14] who inserted MF gel around 2 implants in 2 cases. Both implants achieved good secondary stability, suggesting the potential role of MF in enhancing osseointegration around dental implants.
Although, PRF showed less numerical values of implant ISQ, the implants in this group succeeded and there were no clinically significant differences of results among the investigated groups. This is in accordance with and Oncu et al. [9] who compared the stability of dental implants inserted in a one-stage surgical protocol with or without PRF application. In that study, PRF application increased implant stability during the early healing period, as evidenced by higher ISQ values. The authors suggested that, simple application of this material seemed to provide faster osseointegration.
Group 2 compared to group1 showed significantly higher RBD as revealed by CBCT. This may be due to added densities of materials used to manufacture MF gel, which possibly resulted in false higher RBD measurements at the baseline, with little difference between the baseline and 6 months of loading measurements. The present study also agrees with the findings of Shaarawy and Fahmy [24], and Oncu et al. [9], who demonstrated that PRF enlarged both the amount and rate of new bone creation and enhanced bone-to-implant contact throughout the initial stages of healing.
Both studied groups showed a statistically significant increase in mean CBL at loading and 6 months after loading. The differences were statistically significant among both groups in favor of group 2. This may be interpreted clinically as the possible combined enhancement of efficacy of growth factors released by PRF and osteogenic potential of MF. Furthermore, these results may provide support for other studies that reported a reduction of bone resorption due to either topical [11,14,25] or systemic administration [26,27] of MF. The CBL values in this study in both groups were less than those recorded in the study of Tang et al. [28] and Garcez et al [29], who used chisels, drills, and a specific Extension Crest device for crest splitting. Mean CBL of the PRF group in the present study matches well with the results of Cortese et al. [30] who used flapless SCT with autologous PRF around placed implants.
Peri-implant probing around the implant was a good predictor of CBL in the present study, as the results of PD almost followed the same results of CBL in both groups. In the PRF group that had greater CBL, there was a greater and statistically significant increase in PD at 6 months after loading compared to the other groups. This supports the findings of Quirynen et al [31], and Bragger et al. [32].
It has been considered that any gain of ACW represents success of the SCT and depends on many factors including the diameter of the placed implants [33]. Both groups in the present study acquired significant ACW. The results at the time of loading were nearly equal to those of Waechter et al. [33], de Souza et al. [34], and Anitua et al. [5].
At all evaluation periods of the present study, patients in the two groups showed generally good oral hygiene habits, and a healthy state of the soft tissue around the implants, as well as no statistically significant difference in mean gingival and plaque indices scores. This may further emphasize the excellent biocompatibility of 1% metformin gel.
Conclusion
The results of the present study may provide a clinical evidence for the possible osteogenic potential of
MF, indicated that, adding it to PRF which is known with short time stability may increase its therapeutic
performance.
Bibliography
Hi!
We're here to answer your questions!
Send us a message via Whatsapp, and we'll reply the moment we're available!